Literature DB >> 27681436

Mammary Tumor-Associated RNAs Impact Tumor Cell Proliferation, Invasion, and Migration.

Sarah D Diermeier1, Kung-Chi Chang2, Susan M Freier3, Junyan Song4, Osama El Demerdash1, Alexander Krasnitz4, Frank Rigo3, C Frank Bennett3, David L Spector5.   

Abstract

Long non-coding RNAs (lncRNAs) represent the largest and most diverse class of non-coding RNAs, comprising almost 16,000 currently annotated transcripts in human and 10,000 in mouse. Here, we investigated the role of lncRNAs in mammary tumors by performing RNA-seq on tumor sections and organoids derived from MMTV-PyMT and MMTV-Neu-NDL mice. We identified several hundred lncRNAs that were overexpressed compared to normal mammary epithelium. Among these potentially oncogenic lncRNAs we prioritized a subset as Mammary Tumor Associated RNAs (MaTARs) and determined their human counterparts, hMaTARs. To functionally validate the role of MaTARs, we performed antisense knockdown and observed reduced cell proliferation, invasion, and/or organoid branching in a cancer-specific context. Assessing the expression of hMaTARs in human breast tumors revealed that 19 hMaTARs are significantly upregulated and many of these correlate with breast cancer subtype and/or hormone receptor status, indicating potential clinical relevance.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3D organoid culture; antisense oligonucleotides; breast cancer; long non-coding RNAs; mammary tumor; transcriptome

Mesh:

Substances:

Year:  2016        PMID: 27681436      PMCID: PMC5079290          DOI: 10.1016/j.celrep.2016.08.081

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  67 in total

Review 1.  Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.

Authors:  Richard S Geary; Daniel Norris; Rosie Yu; C Frank Bennett
Journal:  Adv Drug Deliv Rev       Date:  2015-02-07       Impact factor: 15.470

2.  Collective invasion in breast cancer requires a conserved basal epithelial program.

Authors:  Kevin J Cheung; Edward Gabrielson; Zena Werb; Andrew J Ewald
Journal:  Cell       Date:  2013-12-12       Impact factor: 41.582

Review 3.  The four dimensions of noncoding RNA conservation.

Authors:  Sven Diederichs
Journal:  Trends Genet       Date:  2014-03-07       Impact factor: 11.639

Review 4.  Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver.

Authors:  C Chang; S O Lee; S Yeh; T M Chang
Journal:  Oncogene       Date:  2013-07-22       Impact factor: 9.867

5.  The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium.

Authors:  Jimmie E Fata; Hidetoshi Mori; Andrew J Ewald; Hui Zhang; Evelyn Yao; Zena Werb; Mina J Bissell
Journal:  Dev Biol       Date:  2007-03-16       Impact factor: 3.582

6.  Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane.

Authors:  M H Barcellos-Hoff; J Aggeler; T G Ram; M J Bissell
Journal:  Development       Date:  1989-02       Impact factor: 6.868

7.  The transcriptional landscape of the mammalian genome.

Authors:  P Carninci; T Kasukawa; S Katayama; J Gough; M C Frith; N Maeda; R Oyama; T Ravasi; B Lenhard; C Wells; R Kodzius; K Shimokawa; V B Bajic; S E Brenner; S Batalov; A R R Forrest; M Zavolan; M J Davis; L G Wilming; V Aidinis; J E Allen; A Ambesi-Impiombato; R Apweiler; R N Aturaliya; T L Bailey; M Bansal; L Baxter; K W Beisel; T Bersano; H Bono; A M Chalk; K P Chiu; V Choudhary; A Christoffels; D R Clutterbuck; M L Crowe; E Dalla; B P Dalrymple; B de Bono; G Della Gatta; D di Bernardo; T Down; P Engstrom; M Fagiolini; G Faulkner; C F Fletcher; T Fukushima; M Furuno; S Futaki; M Gariboldi; P Georgii-Hemming; T R Gingeras; T Gojobori; R E Green; S Gustincich; M Harbers; Y Hayashi; T K Hensch; N Hirokawa; D Hill; L Huminiecki; M Iacono; K Ikeo; A Iwama; T Ishikawa; M Jakt; A Kanapin; M Katoh; Y Kawasawa; J Kelso; H Kitamura; H Kitano; G Kollias; S P T Krishnan; A Kruger; S K Kummerfeld; I V Kurochkin; L F Lareau; D Lazarevic; L Lipovich; J Liu; S Liuni; S McWilliam; M Madan Babu; M Madera; L Marchionni; H Matsuda; S Matsuzawa; H Miki; F Mignone; S Miyake; K Morris; S Mottagui-Tabar; N Mulder; N Nakano; H Nakauchi; P Ng; R Nilsson; S Nishiguchi; S Nishikawa; F Nori; O Ohara; Y Okazaki; V Orlando; K C Pang; W J Pavan; G Pavesi; G Pesole; N Petrovsky; S Piazza; J Reed; J F Reid; B Z Ring; M Ringwald; B Rost; Y Ruan; S L Salzberg; A Sandelin; C Schneider; C Schönbach; K Sekiguchi; C A M Semple; S Seno; L Sessa; Y Sheng; Y Shibata; H Shimada; K Shimada; D Silva; B Sinclair; S Sperling; E Stupka; K Sugiura; R Sultana; Y Takenaka; K Taki; K Tammoja; S L Tan; S Tang; M S Taylor; J Tegner; S A Teichmann; H R Ueda; E van Nimwegen; R Verardo; C L Wei; K Yagi; H Yamanishi; E Zabarovsky; S Zhu; A Zimmer; W Hide; C Bult; S M Grimmond; R D Teasdale; E T Liu; V Brusic; J Quackenbush; C Wahlestedt; J S Mattick; D A Hume; C Kai; D Sasaki; Y Tomaru; S Fukuda; M Kanamori-Katayama; M Suzuki; J Aoki; T Arakawa; J Iida; K Imamura; M Itoh; T Kato; H Kawaji; N Kawagashira; T Kawashima; M Kojima; S Kondo; H Konno; K Nakano; N Ninomiya; T Nishio; M Okada; C Plessy; K Shibata; T Shiraki; S Suzuki; M Tagami; K Waki; A Watahiki; Y Okamura-Oho; H Suzuki; J Kawai; Y Hayashizaki
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

8.  A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation.

Authors:  Saori Tomita; Mohamed Osama Ali Abdalla; Saori Fujiwara; Haruka Matsumori; Kazumitsu Maehara; Yasuyuki Ohkawa; Hirotaka Iwase; Noriko Saitoh; Mitsuyoshi Nakao
Journal:  Nat Commun       Date:  2015-04-29       Impact factor: 14.919

9.  HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression.

Authors:  Shiuh-Dih Chou; Ayesha Murshid; Takanori Eguchi; Jianlin Gong; Stuart K Calderwood
Journal:  Oncogene       Date:  2014-06-23       Impact factor: 9.867

10.  CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model.

Authors:  Liguo Wang; Hyun Jung Park; Surendra Dasari; Shengqin Wang; Jean-Pierre Kocher; Wei Li
Journal:  Nucleic Acids Res       Date:  2013-01-17       Impact factor: 16.971

View more
  21 in total

1.  The Cancer Genomics Cloud: Collaborative, Reproducible, and Democratized-A New Paradigm in Large-Scale Computational Research.

Authors:  Jessica W Lau; Erik Lehnert; Anurag Sethi; Raunaq Malhotra; Gaurav Kaushik; Zeynep Onder; Nick Groves-Kirkby; Aleksandar Mihajlovic; Jack DiGiovanna; Mladen Srdic; Dragan Bajcic; Jelena Radenkovic; Vladimir Mladenovic; Damir Krstanovic; Vladan Arsenijevic; Djordje Klisic; Milan Mitrovic; Igor Bogicevic; Deniz Kural; Brandi Davis-Dusenbery
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

2.  Long non-coding RNA LINC00243 promotes proliferation and glycolysis in non-small cell lung cancer cells by positively regulating PDK4 through sponging miR-507.

Authors:  Xuegang Feng; Shengsheng Yang
Journal:  Mol Cell Biochem       Date:  2019-10-08       Impact factor: 3.396

Review 3.  The potential application of organoids in breast cancer research and treatment.

Authors:  Nasim Ebrahimi; Alireza Nasr Esfahani; Setare Samizade; Atena Mansouri; Masoud Ghanaatian; Samaneh Adelian; Vida Shadman Manesh; Michael R Hamblin
Journal:  Hum Genet       Date:  2021-10-28       Impact factor: 4.132

4.  Long non-coding RNA lncHUPC1 induced by FOXA1 promotes tumor progression by inhibiting apoptosis via miR-133b/SDCCAG3 in prostate cancer.

Authors:  Miao Liu; Ai Shen; Yongbo Zheng; Xiong Chen; Leilei Wang; Ting Li; Xin Ouyang; Xian Yu; Hao Sun; Xiaohou Wu
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

Review 5.  Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities.

Authors:  Jenny Lange; Haiyan Zhou; Amy McTague
Journal:  Front Mol Neurosci       Date:  2022-06-27       Impact factor: 6.261

6.  Antisense Oligonucleotide-mediated Knockdown in Mammary Tumor Organoids.

Authors:  Sarah D Diermeier; David L Spector
Journal:  Bio Protoc       Date:  2017-08-20

Review 7.  Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments.

Authors:  Javier Martinez-Useros; Mario Martin-Galan; Maria Florez-Cespedes; Jesus Garcia-Foncillas
Journal:  Cancers (Basel)       Date:  2021-06-27       Impact factor: 6.639

8.  MaTAR25: a long non-coding RNA involved in breast cancer progression.

Authors:  Kung-Chi Chang; David L Spector
Journal:  Mol Cell Oncol       Date:  2021-02-22

Review 9.  Therapeutic Targeting of Long Non-Coding RNAs in Cancer.

Authors:  Gayatri Arun; Sarah D Diermeier; David L Spector
Journal:  Trends Mol Med       Date:  2018-02-12       Impact factor: 15.272

10.  Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes.

Authors:  Kiyoko Setoguchi; Lin Cui; Nobutaka Hachisuka; Sumalee Obchoei; Kentaro Shinkai; Fuminori Hyodo; Kiyoko Kato; Fumito Wada; Tsuyoshi Yamamoto; Mariko Harada-Shiba; Satoshi Obika; Kenji Nakano
Journal:  Mol Ther Nucleic Acids       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.